NEXGEL INC - COMMON STOCK

NEXGEL Announces Preliminary Record Second Quarter 2024 Revenue of $1.4 Million and Issues Revenue Guidance for Third and Fourth Quarter of 2024 of $2.2 Million and $2.6 Million, Respectively

08 Jul 2024 16:05:00 By Nasdaq GlobeNewswire

NEXGEL Subsidiary, CG Converting and Packaging, Announces it will Supply SilverSeal to Cintas Corporation

27 Jun 2024 09:00:00 By Nasdaq GlobeNewswire

NEXGEL and STADA Partner to Launch Leading European DAO Enzyme Supplement, Histasolv, in North America

11 Jun 2024 08:40:00 By Nasdaq GlobeNewswire

NEXGEL Acquires International Beauty Brand, Silly George

16 May 2024 09:00:00 By Nasdaq GlobeNewswire

NEXGEL Reports First Quarter 2024 Revenue of $1.27 Million, an Increase of 104% Year-Over-Year

13 May 2024 16:05:00 By Nasdaq GlobeNewswire

NEXGEL to Report First Quarter 2024 Financial Results on May 13th

09 May 2024 08:00:00 By Nasdaq GlobeNewswire

NEXGEL to Present at the Aegis Capital Virtual Conference on May 9, 2024

06 May 2024 16:05:00 By Nasdaq GlobeNewswire

NEXGEL to Present at the Planet MicroCap Showcase: VEGAS 2024, May 1 & 2, 2024

18 Apr 2024 08:00:00 By Nasdaq GlobeNewswire

NEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an Increase of 99.7% Year-Over-Year

01 Apr 2024 07:50:00 By Nasdaq GlobeNewswire

NEXGEL Reschedules Fourth Quarter and Full Year 2023 Financial Results Conference Call to Monday, April 1st at 8:30 a.m. ET Due to Holiday

27 Mar 2024 09:00:00 By Nasdaq GlobeNewswire

NEXGEL to Report Fourth Quarter and Full Year 2023 Financial Results on March 28th

21 Mar 2024 09:00:00 By Nasdaq GlobeNewswire

NEXGEL to Present at the iAccess Alpha Best Ideas Spring Virtual Conference on March 12th

04 Mar 2024 08:30:00 By Nasdaq GlobeNewswire

NEXGEL Announces $975,000 Registered Direct Offering Led by Insiders

21 Feb 2024 16:05:00 By Nasdaq GlobeNewswire

NEXGEL to Present at The Microcap Conference, January 30th through February 1st

18 Jan 2024 09:00:00 By Nasdaq GlobeNewswire

NEXGEL Subsidiary, CG Converting and Packaging, Begins 12,000 Square Foot Expansion of Texas Facility to Support the Expected Growth in Product Demand in 2024

09 Jan 2024 08:30:00 By Nasdaq GlobeNewswire

NEXGEL Announces Partnership with STADA to Distribute and Commercialize Consumer Health OTC Products in North America

11 Dec 2023 08:00:00 By Nasdaq GlobeNewswire

NEXGEL Acquires Kenkoderm Psoriasis Skincare Line

05 Dec 2023 08:00:00 By Nasdaq GlobeNewswire

NEXGEL Reports Record Third Quarter 2023 Revenue of $1.2 Million, an Increase of 115% Year-Over-Year

13 Nov 2023 16:05:01 By Nasdaq GlobeNewswire

NEXGEL to Report Third Quarter 2023 Financial Results on November 13th

02 Nov 2023 09:00:00 By Nasdaq GlobeNewswire

NEXGEL Secures Supply Agreement with AbbVie

30 Oct 2023 08:00:00 By Nasdaq GlobeNewswire